Blood sugar tests help manage diabetes by monitoring glucose levels in the blood. High blood sugar can cause symptoms like thirst, blurry vision, and fatigue. Over time, too much glucose can damage ...

Shares of Northfield-based Medline jumped 41% during the company’s first day of trading Wednesday, after it raised $6.26 billion in the largest initial public offering of the year. Medline’s stock ...

Medline is now on Nasdaq. Medline raised $6.26 billion in the largest US IPO since 2021. Overwhelming demand led to an upsized offering of 216 million shares. Medline offers 190,000 products, 43,000 ...

Medline (MDLN) is back on investor radars after a quiet stretch, with the stock hovering around 29 dollars despite sizable annual revenue and steady profitability that invite a closer look at ...

It’s been a tumultuous year for U.S. stock markets. Investors have had their nerves rattled twice this year by government-related events—President Trump’s Liberation Day tariffs in the spring, ...

Medline—the mammoth medical device distributor that has largely worked behind the scenes and out of the headlines to stock hospitals and operating rooms—is now taking center stage with one of the ...

The listing will overshadow the $5.3 billion raised in May by Chinese battery company Contemporary Amperex Technology Co, known as CATL, the Financial Times reported. (Image: X) Medline Inc. has ...

Medline Inc. shares surged 21% in their trading debut Wednesday, after the medical supplier raised $6.26 billion in the year’s biggest initial public offering. Related Articles President Trump’s bid ...

The public trading debut of medical supply giant Medline will go down as the biggest global IPO of 2025. That’s impressive in and of itself, but it’s even more impressive given that the company is not ...

Medline signage during the company's IPO at the Nasdaq MarketSite in Times Square. (Michael Nagle/Bloomberg News) Shares of Medline, a medical-supplies manufacturer and distributor, rose 41% in their ...

Medical-supplies distributor Medline has raised $6.26 billion in an initial public offering, taking the title of biggest IPO of the year and a valuation of more than $50 billion. The U.S.-based ...